Skip to content

Category Archives: EndoBarrier Gastrointestinal Liner

Novel Gastrointestinal Interventional Therapies > Endolumenal application > GI Dynamics > Gut-Lining Device > Combats Diabetes > Obesity Clinical Trial > Reduced blood sugar > More invasive procedures might carry more risk > Harvard Medical School > Reversible > Device can be retrieved via the mouth > First World Congress on Interventional Therapies for Type 2 Diabetes > EndoBarrier Gastrointestinal Liner Data > Patients with Type 2 Diabetes > Presented at the First World Congress > Interventional Therapies for Type 2 Diabetes

Thursday, September 18, 2008

Has the EndoBarrier potential to provide immediate metabolic control with less risk? Are these the most exciting and promising device data from endoscopic devices? Has this disease has reached epidemic proportions around the globe? Is there a substantial unmet need for a simple and safe approach for patients to achieve metabolic control?

IIP > read on […]

Filed in Prospective randomized sham-controlled clinical trial, Clinical-stage medical device company, Deliver immediate metabolic control, Modifying metabolic pathways, Endoluminal Therapies for Type 2 Diabetes, Keynote lecture, Novel Gastrointestinal Interventional Therapies, Lee M Kaplan, Weight Center, Orally delivered, Removable device, Health policy makers, Public health authorities and insurers, Seize the opportunity, Novel interventional therapies, Forum for the medical community, Comprehensive and multidisciplinary forum, Lines a portion of the small intestine, Top-tier investors, Catalyst Health Ventures, Treat obesity and type 2 diabetes, Noninvasive device, Domain Associates, Johnson & Johnson Development Corporation, Polaris Venture Partners, Bariatric surgery, Cutlass Capital, Advanced Technology Ventures, New York Presbyterian Hospital, Weill Cornell Medical College, GI Dynamics, Type 2 diabetes, Clinical Trial, Patients with Type 2 Diabetes, First World Congress on Interventional Therapies, Pioneering new approaches to treating metabolic disorde, Medical Device Company, EndoBarrier Gastrointestinal Liner, Gastrointestinal surgery, Resulting in weight loss, Improved glycemic control, Massachusetts General Hospital | Comments Off

GI Dynamics > Clinical-stage medical device company > New noninvasive approaches to treat obesity > Type 2 diabetes > Related metabolic diseases > EndoBarrier technology > EndoBarrier Gastrointestinal Liner > Orally delivered > Removable device > Lines portion of small intestine > Immediate metabolic control with less risk

Thursday, September 11, 2008

Has GI Dynamics developed therapies resulting in weight loss and improved glycemic control? Is the technology designed to deliver immediate metabolic control by modifying metabolic pathways? Will EndoBarrier application data be presented at the 1st World Congress on Interventional Therapies for Type 2 Diabetes?

IIP > read on here > http://www.earthtimes.org…
Data from Clinical Trial of EndoBarrier(TM) […]

Filed in Corporate Acquisitions, Medical Ventures, Financing to Advance Commercialization, Expanded Portfolio, Three-way merger, Absorption of nutrients, First part of the small intestine, Obesity medicine, Obesity and diabetes, Obesity dragging down our health care system, Most effective treatment for obesity, Intestinal barrier device, Pre-commercial stage medical device companies, Alternative to Gastric Bypass, Pouch enlargement or dilatation of the gastrojejunostom, Patients Who Gain Weight After Bariatric Surgery, LAGB banding costs $17, Other bariatric weight loss operations cost $25, Diabetes is killing about 73, Natural Orifice Transgastric Endoscopic Surgery NOTES, Dmitry Nepomnayshy, Effect mimics gastric bypass, EndoBarrier Gastrointestinal Liner, Non-surgical alternative to gastric bypass, Route for resolving type 2 diabetes, Lahey Clinic, Natural Orifice Translumenal Endoscopic Surgery NOTES, Obesity is a complex condition, Weight Re-gain After Gastric Bypass, home by the day after surgery, Reduces Size of Stomach Pouch, Morbid obesity, Body mass index of greater than 50, Obesity, Treatment Of Obesity, Natural orifices such as the mouth rectum or vagina, Bodies' natural orifices, Risk factor obesity, Natural Orifice Transluminal Endoscopic Surgery NOTES, Body mass index, Surgical obesity intervention, Gastric bypass pouch and stoma reduction, Leak-proof closure, Natural Orifice Trans Umbilical Surgery NOTUS, Natural orifices tranlumenal endosurgery NOTES, natural orifice, Obesity Surgery, Laparoscopic Adjustable Gastric Banding LAGB, Metabolic disorder, Metabolic Diseases, Nutrition Disorders, Overweight, Overnutrition, Natural orifice transluminal endoscopic surgery | Comments Off

Intestinal Barrier > Alternative to Gastric Bypass > EndoBarrier Gastrointestinal Liner > Lexington-based GI Dynamics > Effect mimicsgastric bypass > non-surgical alternative to gastric bypass > Route for resolving type 2 diabetes

Wednesday, July 9, 2008

Is obesity dragging down our health care system? Is there another treatment option besides bypass surgery with an intestinal barrier device? Is it sufficient to cover the first part of the small intestine where the absorption of nutrients takes place?

IIP > read on here > http://www.redorbit.com…
…Doctors at Lahey Clinic are investigating a new device that […]

Filed in Obesity dragging down our health care system, Obesity medicine, Most effective treatment for obesity, Intestinal barrier device, First part of the small intestine, Obesity and diabetes, Natural Orifice Translumenal Endoscopic Surgery NOTES, Natural orifices tranlumenal endosurgery NOTES, Leak-proof closure, natural orifice, Obesity Surgery, Obesity is a complex condition, Absorption of nutrients, Medical Ventures, Non-surgical alternative to gastric bypass, Effect mimics gastric bypass, Route for resolving type 2 diabetes, Lahey Clinic, Dmitry Nepomnayshy, EndoBarrier Gastrointestinal Liner, Alternative to Gastric Bypass, Financing to Advance Commercialization, Corporate Acquisitions, Expanded Portfolio, Three-way merger, Pre-commercial stage medical device companies, Natural Orifice Trans Umbilical Surgery NOTUS, Diabetes is killing about 73,000 people in the U.S. eac, Obesity, Treatment Of Obesity, home by the day after surgery, Weight Re-gain After Gastric Bypass, Reduces Size of Stomach Pouch, Body mass index, Natural Orifice Transgastric Endoscopic Surgery NOTES, Bodies' natural orifices, Natural orifice transluminal endoscopic surgery, Natural orifices such as the mouth rectum or vagina, Risk factor obesity, Natural Orifice Transluminal Endoscopic Surgery NOTES, Patients Who Gain Weight After Bariatric Surgery, Morbid obesity, Metabolic disorder, Overnutrition, Laparoscopic Adjustable Gastric Banding LAGB, LAGB banding costs $17,000 in the USA, Other bariatric weight loss operations cost $25,000 in , Overweight, Nutrition Disorders, Surgical obesity intervention, Body mass index of greater than 50, Gastric bypass pouch and stoma reduction, Pouch enlargement or dilatation of the gastrojejunostom, Metabolic Diseases, Natural Orifice Transluminal Endoscopic Surgery | Comments Off